In-Vitro Fertilization (IVF) Market Size, Share, Trends, Analysis and Forecast 2018-2023

IVF plays the crucial role in the healthcare sector for infertility treatment. IVF is an assisted reproduction technique (ART) used for combining egg and sperm outside the body and then monitoring and stimulating the entire process. The ART is a procedure to achieve pregnancy by techniques such as in vitro fertilization, Surrogacy, and fertility medication. The IVF can be done by two fertilization methods that are insemination and intracytoplasmic sperm injection (ICSI). The devices used for this treatment are special microscope, incubators, ultrasound machines, IVF disposables and other such devices. The increasing trends of assisted reproductive technology and increasing infertility rate due to the lifestyle change is the major growth factor for in-vitro fertilization market. Furthermore, the rising ovulation disorder and usage of preimplantation genetic screening or diagnosis in healthcare sector can drive the market growth of IVF.

A full report of Global In-Vitro Fertilization (IVF) Market is available at: https://www.omrglobal.com/industry-reports/in-vitro-fertilization-market

The high cost of IVF treatment and the side effects associated with it such as risk of multiple births and risk of spread of infectious diseases can be the major threat for the growth of IVF market. However, the development of new products such as cryopreservation and IMSI technology will create huge opportunity for this market. The cryopreservation technology will support the IVF treatment by preserving the embryos or sperm of the donor for the further treatment. Additionally, the adoption of novel sperm sorting devices will drive the market growth of IVF in future. Moreover, there are companies in the market that are investing significantly which in turn enhance the overall market growth.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/in-vitro-fertilization-market

Geographically market is divided into North America, Europe, Asia Pacific and Rest of the World. Europe is expected to hold the largest share in IVF market. The reason behind this being a dominating region is the introduction of newer techniques with better success rate and affordable cost. In addition, funding offered by the government in the region further enhance the market growth. For example: the government of Ontario in 2016 announced $ 50 million fertility program for covering IVF treatment for 5,000 people. Furthermore, Asia Pacific is expected to witness the highest CAGR during the forecast period.

There are various companies who are involved in the IVF business such as Vitrolife AB, Thermo Fisher Scientific Inc., OvaScience, Merck KGaA, GE Healthcare, CombiMatrix, BioMerieux SA, Abbott Laboratories, Esco Micro Pte. Ltd., Genea Limited, and so on. The companies are working on developing IVF and on research of new IVF procedures, expansion M&A, finding new market or innovate in their core competency in order to expand individual market share. These players are adopting growth strategies such as partnership and collaboration and product launch coupled with innovation. For example: GE healthcare and Vitrolife in July 2018 collaborated for improving assisted reproductive technologies offerings.

Global In-Vitro Fertilization (IVF) Market- Segmentation

By Procedure

• Frozen Donor
• Frozen Non-Donor
• Fresh Donor
• Fresh Non-Donor
• Embryo Banking

By End-User

• Hospitals
• Fertility Clinics
• Research Institutions

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/in-vitro-fertilization-market

Global In-Vitro Fertilization (IVF) Market– Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles
• Abbott Laboratories Inc.
• Anecova SA
• bioMerieux SA
• Celmatix Inc.
• CombiMatrix Corp.
• Cook Medical Inc
• Cooper Surgical Inc.
• EMD Serono, Inc.
• Esco Micro Pte Ltd.
• Ferring Holding SA
• GE Healthcare
• Genea Limited
• IKS International B.V.
• Illumina, Inc
• Incept BioSystems, Inc.
• Inventia Genetic Technologies Pty Ltd
• INVO Bioscience Inc
• Irvine Scientific Sales Company, Inc.
• Merck & Co.
• Nidacon International AB
• Nikon Instruments, Inc.
• OvaScience, Inc.
• Pantec BioSolutions AG
• Planer PLC Group
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Smiths Medical, Inc.
• Thermo Fisher Scientific Inc.
• Vitrolife

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

This release was published on openPR.